Patents Assigned to NAVI BIO-THERAPEUTICS, INC.
  • Antibody specific to nectin cell adhesion molecule 4 and uses thereof
    Patent number: 12258402
    Abstract: The present disclosure relates to a modified antibody, or antigen-binding fragment thereof, specific for nectin cell adhesion molecule 4 (nectin-4). The present disclosure also relates to a method of detecting or diagnosing whether a subject has, or is at risk of developing a tumor, or assessing a prognosis of a tumor and a pharmaceutical composition for use in treating, prophylactic treating and/or preventing tumor in a subject afflicted with the tumor.
    Type: Grant
    Filed: January 12, 2023
    Date of Patent: March 25, 2025
    Assignee: NAVI BIO-THERAPEUTICS, INC.
    Inventors: Bor-Yu Tsai, Shin-Tsung Huang, Wei-Ting Hsu